{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:25:18Z","timestamp":1785241518033,"version":"3.55.0"},"reference-count":170,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1053\/j.ajkd.2011.12.035","type":"journal-article","created":{"date-parts":[[2012,5,5]],"date-time":"2012-05-05T07:16:50Z","timestamp":1336202210000},"page":"139-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Ergocalciferol and Cholecalciferol in CKD"],"prefix":"10.1053","volume":"60","clinical-trial-number":[{"clinical-trial-number":"nct00749736","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00892099","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00893451","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01026363","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01323712","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01426724","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sagar U.","family":"Nigwekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishir","family":"Bhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thadhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2105\/AJPH.12.2.104","article-title":"The prevention and cure of rickets by sunlight","volume":"12","author":"Hess","year":"1922","journal-title":"Am J Public Health (N Y)"},{"key":"10.1053\/j.ajkd.2011.12.035_bib4","first-page":"76","article-title":"The distillation of vitamin D","volume":"B107","author":"Askew","year":"1931","journal-title":"Proceedings of the Royal Society"},{"issue":"5291","key":"10.1053\/j.ajkd.2011.12.035_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/230228a0","article-title":"Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism","volume":"230","author":"Lawson","year":"1971","journal-title":"Nature"},{"issue":"5273","key":"10.1053\/j.ajkd.2011.12.035_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/228764a0","article-title":"Unique biosynthesis by kidney of a biological active vitamin D metabolite","volume":"228","author":"Fraser","year":"1970","journal-title":"Nature"},{"issue":"7804","key":"10.1053\/j.ajkd.2011.12.035_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(73)92197-1","article-title":"Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency","volume":"1","author":"Mawer","year":"1973","journal-title":"Lancet"},{"issue":"3-5","key":"10.1053\/j.ajkd.2011.12.035_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jsbmb.2006.12.089","article-title":"Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?","volume":"103","author":"Brown","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2215\/CJN.03850907","article-title":"Battleground: chronic kidney disorders mineral and bone disease\u2014calcium obsession, vitamin D, and binder confusion","volume":"3","author":"Kovesdy","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneph0977","article-title":"Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?","volume":"5","author":"Wetmore","year":"2009","journal-title":"Nat Clin Pract Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.035_bib13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib14","first-page":"391","article-title":"Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3","volume":"7","author":"Schwartz","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5(suppl 5)","key":"10.1053\/j.ajkd.2011.12.035_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/ajkd.2001.28111","article-title":"Therapeutic uses of vitamin D analogues","volume":"38","author":"Brown","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib16","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5768","key":"10.1053\/j.ajkd.2011.12.035_bib17","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"issue":"23","key":"10.1053\/j.ajkd.2011.12.035_bib18","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(18)60906-8","article-title":"Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages","volume":"262","author":"Reichel","year":"1987","journal-title":"J Biol Chem"},{"issue":"10(suppl 2)","key":"10.1053\/j.ajkd.2011.12.035_bib19","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1111\/j.1753-4887.2008.00104.x","article-title":"Vitamin D: a D-lightful health perspective","volume":"66","author":"Holick","year":"2008","journal-title":"Nutr Rev"},{"issue":"3-5","key":"10.1053\/j.ajkd.2011.12.035_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jsbmb.2006.12.078","article-title":"Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease","volume":"103","author":"Hewison","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.035_bib21","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","article-title":"Resurrection of vitamin D deficiency and rickets","volume":"116","author":"Holick","year":"2006","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib22","first-page":"888","article-title":"Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase","volume":"86","author":"Zehnder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.035_bib24","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2215\/CJN.02140309","article-title":"Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease","volume":"4","author":"Kalantar-Zadeh","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2215\/CJN.06440909","article-title":"Clinical measures identify vitamin D deficiency in dialysis","volume":"5","author":"Bhan","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1523-1755.1999.0550031019.x","article-title":"Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure","volume":"55","author":"Ishimura","year":"1999","journal-title":"Kidney Int"},{"issue":"4(suppl 3)","key":"10.1053\/j.ajkd.2011.12.035_bib28","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2011.12.035_bib29","first-page":"S1","article-title":"Kidney Disease Improving Global Outcomes","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1-5","key":"10.1053\/j.ajkd.2011.12.035_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jsbmb.2004.03.037","article-title":"Why \u201cvitamin D\u201d is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs or deltanoids","volume":"89-90","author":"Vieth","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.ajkd.2011.12.035_bib35","volume":"Vol 1","author":"Feldman","year":"2011"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jn\/135.2.317","article-title":"Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D","volume":"135","author":"Hollis","year":"2005","journal-title":"J Nutr"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/jc.2010-2760","article-title":"What do we tell our patients about calcium and vitamin D supplementation?","volume":"96","author":"Khosla","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4065\/mcp.2010.0567","article-title":"Vitamin D insufficiency","volume":"86","author":"Thacher","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s001980050030","article-title":"Prevalence of vitamin D insufficiency in an adult normal population","volume":"7","author":"Chapuy","year":"1997","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1525-139X.2010.00751.x","article-title":"Dietary vitamin D intake in advanced CKD\/ESRD","volume":"23","author":"Bhan","year":"2010","journal-title":"Semin Dial"},{"issue":"18","key":"10.1053\/j.ajkd.2011.12.035_bib41","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199204303261808","article-title":"Vitamin D\u2014solar rays, the Milky Way, or both?","volume":"326","author":"Haddad","year":"1992","journal-title":"N Engl J Med"},{"issue":"8026","key":"10.1053\/j.ajkd.2011.12.035_bib42","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(77)92553-3","article-title":"Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D","volume":"1","author":"Stamp","year":"1977","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.ajkd.2011.12.035_bib43","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/jn\/114.7.1313","article-title":"Defective photoproduction of cholecalciferol in normal and uremic humans","volume":"114","author":"Jacob","year":"1984","journal-title":"J Nutr"},{"issue":"8263","key":"10.1053\/j.ajkd.2011.12.035_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(82)90214-8","article-title":"Increased skin pigment reduces the capacity of skin to synthesise vitamin D3","volume":"1","author":"Clemens","year":"1982","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib45","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2010-2230","article-title":"Vitamin D(3) is more potent than vitamin D(2) in humans","volume":"96","author":"Heaney","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"10.1053\/j.ajkd.2011.12.035_bib46","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase","volume":"101","author":"Cheng","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ecl.2010.02.002","article-title":"Vitamin D: metabolism","volume":"39","author":"Christakos","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib48","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1172\/JCI111568","article-title":"Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man","volume":"74","author":"Bell","year":"1984","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2006.04.116","article-title":"Isolation and properties of the CYP2D25 promoter: transcriptional regulation by vitamin D3 metabolites","volume":"345","author":"Ellfolk","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ecl.2010.02.012","article-title":"Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment","volume":"39","author":"Hollis","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib51","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1210\/jcem-63-4-954","article-title":"Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein","volume":"63","author":"Bikle","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib52","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1046\/j.1523-1755.2002.00634.x","article-title":"Expression profiling confirms the role of endocytic receptor megalin in renal vitamin D3 metabolism","volume":"62","author":"Hilpert","year":"2002","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00041433-200206000-00004","article-title":"Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3","volume":"13","author":"Willnow","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"issue":"5333","key":"10.1053\/j.ajkd.2011.12.035_bib55","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1126\/science.277.5333.1827","article-title":"25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis","volume":"277","author":"Takeyama","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1677\/jme.0.0250141","article-title":"1alpha-Hydroxylase and the action of vitamin D","volume":"25","author":"Hewison","year":"2000","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib57","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V10122465","article-title":"Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney","volume":"10","author":"Zehnder","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ecl.2010.02.005","article-title":"Vitamin D in kidney disease: pathophysiology and the utility of treatment","volume":"39","author":"Qazi","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6(suppl)","key":"10.1053\/j.ajkd.2011.12.035_bib59","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","article-title":"Overview of general physiologic features and functions of vitamin D","volume":"80","author":"DeLuca","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1073\/pnas.68.4.803","article-title":"Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine","volume":"68","author":"Holick","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcb.10331","article-title":"Vitamin D and bone","volume":"88","author":"Suda","year":"2003","journal-title":"J Cell Biochem"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib62","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/ajcn\/80.3.752","article-title":"Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y","volume":"80","author":"Bischoff-Ferrari","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-152-5-201003020-00009","article-title":"Systematic review: vitamin D and cardiometabolic outcomes","volume":"152","author":"Pittas","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.10.033","article-title":"25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey","volume":"205","author":"Kendrick","year":"2009","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib66","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ecl.2010.02.013","article-title":"Vitamin D and diabetes","volume":"39","author":"Takiishi","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"18","key":"10.1053\/j.ajkd.2011.12.035_bib68","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1073\/pnas.0601554103","article-title":"Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib69","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2008.560","article-title":"Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey","volume":"169","author":"Ginde","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2011.12.035_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-483X(02)00257-3","article-title":"Ultraviolet radiation and autoimmune disease: insights from epidemiological research","volume":"181-182","author":"Ponsonby","year":"2002","journal-title":"Toxicology"},{"issue":"6(suppl)","key":"10.1053\/j.ajkd.2011.12.035_bib71","doi-asserted-by":"crossref","first-page":"1717S","DOI":"10.1093\/ajcn\/80.6.1717S","article-title":"Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system","volume":"80","author":"Cantorna","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"104","key":"10.1053\/j.ajkd.2011.12.035_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3003045","article-title":"Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages","volume":"3","author":"Fabri","year":"2011","journal-title":"Sci Transl Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2011.12.035_bib73","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1016\/j.psyneuen.2009.05.023","article-title":"Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases","volume":"34","author":"Fernandes de Abreu","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2011.12.035_bib74","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/j.psyneuen.2009.04.015","article-title":"Developmental vitamin D deficiency causes abnormal brain development","volume":"34","author":"Eyles","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib75","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib76","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2310\/JIM.0b013e318214ea2d","article-title":"Vitamin D: a d-lightful solution for health","volume":"59","author":"Holick","year":"2011","journal-title":"J Investig Med"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.035_bib77","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2215\/CJN.02680310","article-title":"Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23\/Klotho system","volume":"5","author":"Prie","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib78","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1073\/pnas.91.3.900","article-title":"Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene","volume":"91","author":"Zierold","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ndt\/6.3.162","article-title":"Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism","volume":"6","author":"Reichel","year":"1991","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000183383","article-title":"Serum concentrations of vitamin D metabolites in different degrees of impaired renal function","volume":"39","author":"Rickers","year":"1985","journal-title":"Nephron"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib81","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib82","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","article-title":"Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies","volume":"58","author":"Pilz","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib84","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib85","doi-asserted-by":"crossref","first-page":"c204","DOI":"10.1159\/000321507","article-title":"Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS Study","volume":"118","author":"Jean","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1542-4758.2007.00186.x","article-title":"Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis","volume":"11","author":"Del Valle","year":"2007","journal-title":"Hemodial Int"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib87","doi-asserted-by":"crossref","first-page":"HY14","DOI":"10.12659\/MSM.881790","article-title":"Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease","volume":"17","author":"Hu","year":"2011","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib88","first-page":"1876","article-title":"Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables","volume":"46","author":"Holick","year":"1987","journal-title":"Fed Proc"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.035_bib89","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1034\/j.1600-0560.2003.00109.x","article-title":"A current review of the cutaneous manifestations of renal disease","volume":"30","author":"Abdelbaqi-Salhab","year":"2003","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib90","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1525-139X.2005.18408.x","article-title":"Vitamin D treatment in chronic kidney disease","volume":"18","author":"Andress","year":"2005","journal-title":"Semin Dial"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.jrn.2010.10.007","article-title":"Vitamin D biology: from the discovery to its significance in chronic kidney disease","volume":"21","author":"Cuppari","year":"2011","journal-title":"J Ren Nutr"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jrn.2008.10.005","article-title":"Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment","volume":"19","author":"Cuppari","year":"2009","journal-title":"J Ren Nutr"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib93","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ajcn\/37.3.403","article-title":"Impaired intestinal absorption of vitamin D3 in azotemic rats","volume":"37","author":"Vaziri","year":"1983","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11255-006-0081-7","article-title":"25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance","volume":"38","author":"Taskapan","year":"2006","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib95","first-page":"325","article-title":"Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome","volume":"99","author":"Sato","year":"1982","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ki.1992.22","article-title":"Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease","volume":"41","author":"Koenig","year":"1992","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/089686088900900410","article-title":"Vitamin D and vitamin-D-binding protein kinetics in patients treated with continuous ambulatory peritoneal dialysis (CAPD)","volume":"9","author":"Joffe","year":"1989","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000184858","article-title":"Continuous ambulatory peritoneal dialysis and vitamin D","volume":"48","author":"Rapoport","year":"1988","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000183128","article-title":"Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis","volume":"36","author":"Shany","year":"1984","journal-title":"Nephron"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1210\/jcem-59-6-1063","article-title":"Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3","volume":"59","author":"Halloran","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"8195, pt 1","key":"10.1053\/j.ajkd.2011.12.035_bib101","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(80)90283-4","article-title":"Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol","volume":"2","author":"Papapoulos","year":"1980","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib102","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo.140.5.6691","article-title":"Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals","volume":"140","author":"Murayama","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib103","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.2009.175","article-title":"Renoprotective effects of vitamin D analogs","volume":"78","author":"Li","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.035_bib104","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1053\/j.ajkd.2011.12.035_bib106","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib107","first-page":"398","article-title":"Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure","volume":"21","author":"Lu","year":"1995","journal-title":"Miner Electrolyte Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI110586","article-title":"Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1alpha-hydroxylase in the rat kidney","volume":"70","author":"Kawashima","year":"1982","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib109","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.1991.287","article-title":"Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism","volume":"40","author":"Hsu","year":"1991","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.V441035","article-title":"Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure","volume":"4","author":"Vanholder","year":"1993","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib111","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0026-0495(98)90267-0","article-title":"Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout","volume":"47","author":"Takahashi","year":"1998","journal-title":"Metabolism"},{"issue":"24","key":"10.1053\/j.ajkd.2011.12.035_bib112","doi-asserted-by":"crossref","first-page":"13895","DOI":"10.1073\/pnas.241516998","article-title":"Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3)","volume":"98","author":"Nykjaer","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2011.12.035_bib113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1744-9987.2011.00920.x","article-title":"Role of megalin and cubilin in the metabolism of vitamin D(3)","volume":"15","author":"Kaseda","year":"2011","journal-title":"Ther Apher Dial"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib114","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1523-1755.2003.00114.x","article-title":"Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats","volume":"64","author":"Takemoto","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jcem-72-1-157","article-title":"Extrarenal production of calcitriol in normal and uremic humans","volume":"72","author":"Dusso","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib116","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib118","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00041552-199507000-00003","article-title":"Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: calcitriol receptor interaction with its target gene in renal failure","volume":"4","author":"Hsu","year":"1995","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib119","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2337\/diacare.28.5.1228","article-title":"Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib120","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.2337\/diacare.28.12.2926","article-title":"Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women","volume":"28","author":"Liu","year":"2005","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib121","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1797.2011.01450.x","article-title":"Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D","volume":"16","author":"Petchey","year":"2011","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib122","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes","volume":"92","author":"Pittas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"10.1053\/j.ajkd.2011.12.035_bib123","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0021-9681(79)90044-4","article-title":"Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States","volume":"32","author":"Voors","year":"1979","journal-title":"J Chronic Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib124","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ejcn.2009.140","article-title":"Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults","volume":"64","author":"Semba","year":"2010","journal-title":"Eur J Clin Nutr"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.035_bib125","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","article-title":"25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study","volume":"168","author":"Giovannucci","year":"2008","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.035_bib126","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/STROKEAHA.107.513655","article-title":"Low vitamin D levels predict stroke in patients referred to coronary angiography","volume":"39","author":"Pilz","year":"2008","journal-title":"Stroke"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib127","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","article-title":"Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality","volume":"168","author":"Dobnig","year":"2008","journal-title":"Arch Intern Med"},{"issue":"15","key":"10.1053\/j.ajkd.2011.12.035_bib128","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-Hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.035_bib131","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0002-9343(02)01091-4","article-title":"Vitamin D insufficiency among free-living healthy young adults","volume":"112","author":"Tangpricha","year":"2002","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib132","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ajcn\/76.1.187","article-title":"Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994","volume":"76","author":"Nesby-O'Dell","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib133","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib134","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.jrn.2011.02.001","article-title":"Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients","volume":"22","author":"Figuiredo-Dias","year":"2012","journal-title":"J Ren Nutr"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib135","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00260109","article-title":"Vitamin D affects survival independently of vascular calcification in chronic kidney disease","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib136","doi-asserted-by":"crossref","first-page":"149","DOI":"10.33549\/physiolres.931814","article-title":"Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3","volume":"60","author":"Stefikova","year":"2011","journal-title":"Physiol Res"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib137","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib138","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3122\/jabfm.2009.05.080231","article-title":"The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities","volume":"22","author":"Diaz","year":"2009","journal-title":"J Am Board Family Med"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib139","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.jrn.2010.07.002","article-title":"Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions","volume":"21","author":"Isakova","year":"2011","journal-title":"J Ren Nutr"},{"issue":"10","key":"10.1053\/j.ajkd.2011.12.035_bib140","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ajh.2011.108","article-title":"Vitamin D and racial disparity in albuminuria: NHANES 2001-2006","volume":"24","author":"Fiscella","year":"2011","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib141","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10157-007-0023-4","article-title":"Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease","volume":"12","author":"Inaguma","year":"2008","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.035_bib142","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ki.2009.288","article-title":"Chronic kidney disease, hypovitaminosis D, and mortality in the United States","volume":"76","author":"Mehrotra","year":"2009","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib143","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2009030283","article-title":"25-Hydroxyvitamin D levels, race, and the progression of kidney disease","volume":"20","author":"Melamed","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib144","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib145","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ajcn\/87.6.1631","article-title":"Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study","volume":"87","author":"Wang","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib146","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2006060573","article-title":"Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency","volume":"18","author":"London","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib147","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfq606","article-title":"Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD Study","volume":"26","author":"Drechsler","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib148","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11255-010-9723-x","article-title":"Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis","volume":"43","author":"Ambrus","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2011.12.035_bib149","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.02640311","article-title":"Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate","volume":"6","author":"de Boer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.035_bib150","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","article-title":"25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification","volume":"20","author":"de Boer","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib151","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.ajkd.2011.04.028","article-title":"Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD","volume":"58","author":"Navaneethan","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2011.12.035_bib152","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/ndt\/gfq799","article-title":"Nutritional vitamin D in dialysis patients: what to D-iscern?","volume":"26","author":"Nigwekar","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib153","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/oxfordjournals.bmb.a069572","article-title":"Azotaemic renal osteodystrophy","volume":"13","author":"Stanbury","year":"1957","journal-title":"Br Med Bull"},{"key":"10.1053\/j.ajkd.2011.12.035_bib154","first-page":"1","article-title":"The treatment of renal-glomerular osteodystrophy","volume":"30","author":"Dent","year":"1961","journal-title":"Q J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/0003-4819-88-6-774","article-title":"1,25 Dihydroxycholecalciferol effects in chronic dialysis","volume":"88","author":"Berl","year":"1978","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib156","first-page":"219","article-title":"Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology","volume":"10","author":"Malluche","year":"1978","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib157","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib158","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.jrn.2008.04.008","article-title":"Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients","volume":"18","author":"Blair","year":"2008","journal-title":"J Ren Nutr"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib159","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/089686080802800530","article-title":"Effect of vitamin D supplementation on calcidiol and parathyroid hormone levels","volume":"28","author":"Bouchard","year":"2008","journal-title":"Perit Dial Int"},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib160","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.jrn.2011.07.001","article-title":"Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism","volume":"22","author":"Bucharles","year":"2012","journal-title":"J Ren Nutr."},{"issue":"6","key":"10.1053\/j.ajkd.2011.12.035_bib161","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1440-1797.2006.00698.x","article-title":"Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease","volume":"11","author":"DeVille","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib162","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/ndt\/gfp370","article-title":"Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2011.12.035_bib163","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2011.224","article-title":"Oral cholecalciferol decreases albuminuria and urinary TGF-beta1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition","volume":"80","author":"Kim","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib164","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.06510909","article-title":"Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters","volume":"5","author":"Matias","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/089686080502500411","article-title":"Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients","volume":"25","author":"Shah","year":"2005","journal-title":"Perit Dial Int"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib166","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/ndt\/gfn367","article-title":"High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients","volume":"23","author":"Tokmak","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib167","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib168","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1053\/j.ajkd.2011.12.035_bib169","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/08860220801964210","article-title":"Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients","volume":"30","author":"Dogan","year":"2008","journal-title":"Ren Fail"},{"issue":"1","key":"10.1053\/j.ajkd.2011.12.035_bib170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2011.06.027","article-title":"Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial","volume":"59","author":"Kovesdy","year":"2012","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"10.1053\/j.ajkd.2011.12.035_bib171","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.07131009","article-title":"A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease","volume":"5","author":"Moe","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2011.12.035_bib172","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000157177","article-title":"Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease","volume":"31","author":"Oksa","year":"2008","journal-title":"Kidney Blood Press Res"},{"issue":"12","key":"10.1053\/j.ajkd.2011.12.035_bib173","first-page":"38","article-title":"K\/DOQI guidelines released on bone metabolism and disease in CKD","volume":"17","author":"Massry","year":"2003","journal-title":"Nephrol News Issues"},{"issue":"11","key":"10.1053\/j.ajkd.2011.12.035_bib174","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612006361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612006361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:59:37Z","timestamp":1759456777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638612006361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0272638612006361"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.12.035","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ergocalciferol and Cholecalciferol in CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}